AsterTheriX
AsterTherix is an award-winning oncology drug-discovery company that has developed a pathway-based screening system, TheraSeerTM. Using this screening platform, AsterTherix is developing novel therapeutics that simultaneously impact upon multiple interacting pathways. The company's innovative technology emerged from the founders' laboratories at The University of Liverpool and the early focus of the company is on HSP90 pathways.